Two New Regimens Win FDA Approval for H. Pylori Infection
(MedPage Today) -- The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple Pak), and one with amoxicillin (Voquezna Dual Pak), to treat Helicobacter pylori (H. pylori) infection in adults, drugmaker...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Amoxicillin | Biaxin | Clarithromycin | Helicobacter Pylori | International Medicine & Public Health